HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Ozlem Goker-Alpan Selected Research

Parkinson disease 3

10/2008The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Ozlem Goker-Alpan Research Topics

Disease

18Gaucher Disease (Gaucher's Disease)
05/2014 - 01/2004
8Parkinsonian Disorders (Parkinsonism)
08/2012 - 01/2004
6Parkinson Disease (Parkinson's Disease)
08/2012 - 01/2004
3Fabry Disease (Fabry's Disease)
01/2015 - 01/2015
3Lewy Body Disease (Lewy Body Dementia)
11/2010 - 01/2006
1Heart Failure
01/2015
1Eosinophilic Esophagitis
01/2015
1Thrombocytopenia (Thrombopenia)
04/2014
1Hemorrhage
04/2014
1Fever (Fevers)
04/2014
1Missed Abortion
04/2014
1Anemia
04/2014
1Myoclonic Epilepsies (Myoclonic Encephalopathy)
11/2011
1Hypercholesterolemia
05/2002

Drug/Important Bio-Agent (IBA)

15Glucosylceramidase (Glucocerebrosidase)IBA
08/2012 - 01/2004
3agalsidase alfaIBA
01/2015 - 01/2015
2agalsidase betaFDA Link
01/2015 - 01/2015
1globotriaosylceramide (globotriosylceramide)IBA
01/2015
1GalactosidasesIBA
01/2015
1omalizumab (Xolair)FDA Link
01/2015
1imiglucerase (Cerezyme)FDA Link
05/2014
1Ambroxol (Mucosolvan)IBA
02/2013
1Dopamine (Intropin)FDA LinkGeneric
08/2012
1Glucosylceramides (Glucocerebrosides)IBA
12/2011
1CeramidesIBA
12/2011
1Complementary DNA (cDNA)IBA
11/2011
1Membrane Proteins (Integral Membrane Proteins)IBA
11/2011
1Parkinson disease 3IBA
10/2008
1Leucine (L-Leucine)FDA Link
08/2006
1Phosphotransferases (Kinase)IBA
08/2006
1Levodopa (L Dopa)FDA LinkGeneric
01/2006
1noncerebral juvenile Gaucher diseaseIBA
01/2004
1Biological Markers (Surrogate Marker)IBA
05/2002

Therapy/Procedure

5Enzyme Replacement Therapy
01/2015 - 12/2011